These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2255691)

  • 41. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
    Bellabas M; Khaled S; Khaled NA; Boulahbal F; Chaulet P
    Rev Mal Respir; 1989; 6(1):59-64. PubMed ID: 2648511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Results of the treatment and dispensary observation of patients with chronic destructive pulmonary tuberculosis].
    Repnitskaia ZD
    Probl Tuberk; 1973; 51(5):72-5. PubMed ID: 4757051
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of patients with destructive pulmonary tuberculosis with chemotherapeutic preparations combined with sodium nucleinate].
    Kharakter ZhZ; Pavlenko AV
    Probl Tuberk; 1989; (4):27-30. PubMed ID: 2734260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of ascorbic acid and emoxypin on the efficiency of complex chemotherapy for infiltrative pulmonary tuberculosis].
    Volchegorskiĭ IA; Novoselov PN; Astakhova TV
    Ter Arkh; 2009; 81(11):21-4. PubMed ID: 20141008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu; Chukanov VI; Vasil'eva IA
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effectiveness of the treatment of destructive pulmonary tuberculosis].
    Liabakh PP; Mel'nik VN
    Vrach Delo; 1979 Jul; (7):61-3. PubMed ID: 382635
    [No Abstract]   [Full Text] [Related]  

  • 49. [Resistance and efficacy of treatment in relapse pulmonary tuberculosis].
    Tu D; Zhang L; Su J
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):666-8. PubMed ID: 11225030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM; Belotserkovskiĭ VG
    Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV
    Probl Tuberk Bolezn Legk; 2009; (4):23-7. PubMed ID: 19514450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy of treatment of patients with recurrences of tuberculosis of the respiratory organs].
    Kuznetsova ZA; Chernyshev VM; Kolesnikova ZhIa
    Vrach Delo; 1983 Jul; (7):24-5. PubMed ID: 6624051
    [No Abstract]   [Full Text] [Related]  

  • 55. [The operational control studies of smear positive tuberculosis cases with short-course chemotherapy under the full-course management and supervision].
    Dai YS; Li Q; Duanmu HJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):278-80, 318. PubMed ID: 7712567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy].
    Zhu L; Yan B; Ma W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):645-7. PubMed ID: 11477887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The optimization of the corticosteroid therapy of patients with destructive pulmonary tuberculosis].
    Iareshko AG
    Vrach Delo; 1989 Nov; (11):39-40. PubMed ID: 2514485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
    Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS
    Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Short term treatment of infantile pulmonary tuberculosis].
    Garciá López JR; Vidal López ML; Castán Vidal ML; Borque Andrés C; de José Gómez MI; García Hortelano J
    An Esp Pediatr; 1989 Aug; 31(2):110-3. PubMed ID: 2696390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.